Skip to Main Content

Paper Details

Extended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma.
ESMO Open
15
2023
Author NameAffiliation
Toni K ChoueiriLank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
  • 1 - 1

Datasets

Release 1.2